UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence
The managers of Reflex CES take control of the company with support from Crédit Mutuel Equity and the French Armed Forces Ministry’s Definvest fund, managed by Bpifrance